Biopharma J&J to buy psychiatric drug developer Intra-Cellular for $14.6B – BioPharma Dive January 13, 2025 J&J to buy psychiatric drug developer Intra-Cellular for $14.6B BioPharma Dive About Author adminph See author's posts Post Navigation Previous FDA warns companies about lead contamination and other violationsNext Three drug cocktail shows potential to boost CAR-T cancer therapy More Stories
